Red Blood Cell 2,3-biphosphoglycerate Levels in Patients Treated With Empagliflozin. A Prospective Cohort Study
Latest Information Update: 05 Mar 2024
At a glance
- Drugs Empagliflozin (Primary)
- Indications Heart failure; Renal failure; Type 2 diabetes mellitus
- Focus Pharmacodynamics
Most Recent Events
- 05 Mar 2024 New trial record